Concepedia

Pharmaceutical Treatment for Alzheimer’s Disease and Related Dementias: Utilization and Disparities

Douglas Barthold, Geoffrey Joyce, Patricia Ferido, Emmanuel F. Drabo, Zachary A. Marcum, Shelly L. Gray, Julie Zissimopoulos

Journal of Alzheimer s Disease · 2020 · 89 citations · 29 references

DOIFull text

Open access

Abstract

The use of antidementia drugs is relatively low and varies widely by race/ethnicity. Heterogeneity in timing of initiation and use may affect health and cost outcomes, but these effects merit further study.

References

29

2019 Alzheimer's disease facts and figures

Alzheimer s & Dementia · 2019 · 2.4K citations

, , +25

Behavioral and Psychological Symptoms of Dementia

Joaquim Cerejeira, L. Lagarto, EB Mukaetova-Ladinska · Frontiers in Neurology · 2012 · 1.3K citations · Full text

, , +16

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Robert Howard, Rupert McShane, James Lindesay et al. · New England Journal of Medicine · 2012 · 751 citations · Full text

Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan

M.‐X. Tang, Peter Cross, Howard Andrews et al. · Neurology · 2001 · 720 citations · Full text

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

Ganesh M. Babulal, Yakeel T. Quiroz, Benedict C. Albensi et al. · Alzheimer s & Dementia · 2018 · 525 citations · Full text